William Hoffman - Mar 12, 2023 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
Director
Signature
/s/ Angela Ahmad, attorney-in-fact for William Hoffman
Stock symbol
NARI
Transactions as of
Mar 12, 2023
Transactions value $
-$300,500
Form type
4
Date filed
3/14/2023, 07:09 PM
Previous filing
Feb 17, 2023
Next filing
Mar 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $0 +961K +324.57% $0.00 1.26M Mar 12, 2023 Direct
transaction NARI Common Stock Sale -$301K -5K -0.4% $60.10 1.25M Mar 14, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Restricted Stock Unit Options Exercise $0 -961K -100% $0.00* 0 Mar 12, 2023 Common Stock 961K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $60.00 to $60.47 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Amount represents the vesting in full of restricted stock units (RSUs) granted under the 2011 Plan in August 2019 that were subject to achievement of certain conditions specified in the award agreement, including continued service to the company. 100% of the RSUs vested on the fourth anniversary of the vesting commencement date as all conditions were satisfied.